VOYAPRB - Voya Financial Inc Profile, Share Price, Market Analysis, Charts, Fundamentals

Company Name, Ticker, Competitors, else..

Deficit on Weak Sales the company in the fourth quarter of 2022 earnings season

For the fourth quarter of 2022 earnings season Mannatech Incorporated slipped into loss of $-3.51 per share compare to $1.25 a year before and Income per Share fell from $0.61 per share from the previous financial reporting period.

Sales decreased widely by -13.061 % to $34.34 millions from $39.49 millions in the comparable financial reporting period a year before and sequentially Sales decreased by -3.317 % from $35.51 millions.

Facing challenging business enviroment, with rather steep -13.271 %, Sales decrease, the FEIM in the November to January 31 2023 period

For the financial third quarter of 2022 FEIM reached balanced books of $0.00 per share compare to $-0.08 a year ago and from $-0.25 per share from the prior reporting period.

Sales declined widely by -13.271 % to $10.62 millions from $12.25 millions in the similar reporting period a year ago and sequentially Sales improved by 18.672 % from $8.95 millions.

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

VOYAPRB Company Profile

Deficit on Weak Sales the company in the fourth quarter of 2022 earnings season

Among many corporations, the SVBL published also the first quarter of 2022 results

Rise Gold Corp created some great story for the stock market, exhibiting an important growth in Jan 31 2023 report with operating loss of $-0.382803 millions

In the fiscal period ending fourth quarter of 2022 operating surplus echoed some improvement to $0.390483 millions, at the Major Pharmaceutical Preparations company

Facing challenging business enviroment, with rather steep -13.271 %, Sales decrease, the FEIM in the November to January 31 2023 period


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar CIVB's Profile Stock Price CIVB's Financials Business Description Fundamentals Charts & Quotes CIVB's News Suppliers CIVB's Competitors Customers & Markets Economic Indicators CIVB's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness